BLAUVELT, A.; STROBER, B.; LANGLEY, R.; BURGE, D.; PISENTI, L.; YASSINE, M.; KAVANAGH, S.; ARENDT, C.; ROLLERI, R.; REICH, K. Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S16, 2018. DOI: 10.25251/skin.2.supp.16. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/307. Acesso em: 23 jul. 2024.